Business Overview: DENTSPLY SIRONA Inc. (NASDAQ: XRAY)

---

Executive Summary

DENTSPLY SIRONA Inc. describes itself as the world's largest diversified manufacturer of professional dental products and technologies, selling in roughly 140 countries from its U.S. base. The company spans everything from dental implants and clear aligners to imaging equipment, CAD/CAM systems, and consumables used by dentists and dental labs worldwide.

For full-year 2025, DENTSPLY SIRONA reported $3.68 billion in net sales, a decline of about 3% year over year, alongside a GAAP operating loss driven by impairments and restructuring even as adjusted operating margin remained a healthy 13.8%. The company is mid-way through a multi-year restructuring ("the 2026 Plan") and an ERP overhaul intended to simplify a historically complex, acquisition-built product portfolio.

---

1. Core Business Model & How They Work

DENTSPLY SIRONA manufactures dental products and sells them primarily through third-party distributors, with some product lines (implants, aligners, endodontics) sold more directly to dental labs and practitioners.

[ R&D / product design ] ➡️ [ Manufacturing at global facilities ] ➡️ [ Distribution via Henry Schein, Patterson & others ] ➡️ [ Dental practices, labs & Dental Support Organizations ] ➡️ [ Recurring consumables & service revenue ]

Key Operational Drivers

1. Distributor-led go-to-market: Roughly two-thirds of dental consumable and technology/equipment sales flow through third-party distributors; Henry Schein alone accounted for 13% of 2025 net sales, and Patterson Companies represented 11% of accounts receivable — concentrated channel relationships that cut both ways.
2. Secular demand tailwinds: Aging populations, growth in aesthetic dentistry and clear aligners, and rising dental spending in emerging markets support long-term volume growth, alongside increasing consolidation of independent practices into Dental Support Organizations (DSOs) in the U.S.
3. R&D reinvestment: R&D spend runs around 4% of net sales currently, with a stated plan to raise it toward 5% starting in 2026 — a bet that innovation (digital workflows, DS Core cloud platform, single-visit dentistry) is needed to defend share.
4. Restructuring for simplicity: The "2026 Plan" targets $55–65 million of restructuring charges in exchange for roughly $120 million of annualized savings, reflecting a broader effort to simplify a business built through decades of acquisitions.

---

2. Business Segments

┌──────────────────────────────────────────────┐
│             DENTSPLY SIRONA Inc.               │
└───────────────────────┬────────────────────────┘
                          │
   ┌───────────┬──────────┼──────────┬───────────┐
   ▼           ▼          ▼          ▼           ▼
┌─────────┐┌─────────┐┌─────────┐┌─────────┐┌──────────┐
│Connected││Essential││Orthodon-││Wellspect││          │
│ Tech.   ││ Dental  ││tic &    ││Health-  ││          │
│Solutions││Solutions││Implant  ││care     ││          │
│(imaging,││(consum- ││Solutions││(conti-  ││          │
│CAD/CAM) ││ ables)  ││(aligners││nence    ││          │
│         ││         ││,implants)││care)   ││          │
└─────────┘└─────────┘└─────────┘└─────────┘└──────────┘

Connected Technology Solutions

Equipment & Instruments (imaging systems, handpieces, treatment centers) and CAD/CAM (intraoral scanners, mills, the CEREC system, 3-D printers), increasingly tied together through the DS Core cloud collaboration platform.

Essential Dental Solutions

Endodontic, restorative, and preventive consumables and small equipment — the recurring, repeat-purchase backbone of the business.

Orthodontic and Implant Solutions

SureSmile digital orthodontics and clear aligners, dental implants, digital dentures, and prosthetics — higher-growth categories tied to aesthetic dentistry trends.

Wellspect Healthcare

Urinary and bowel continence care devices — a non-dental business that diversifies revenue outside core dentistry.

---

3. Product Portfolio

---

4. Competitive Landscape

DENTSPLY SIRONA competes in highly fragmented dental markets where no single rival matches its product breadth, but faces focused competitors in specific categories.

             DENTAL COMPETITIVE BREADTH
┌────────────────────────────────────────────────┐
│ High                                             │
│  B    [DENTSPLY SIRONA]                          │
│  R         (broadest portfolio)                  │
│  E                                                │
│  A                        [Align Technology]      │
│  D                          (aligner specialist)   │
│  T                                                │
│  H    [Various regional/single-category rivals]  │
│ Low                                               │
│       └─────────────────────────────────────────►│
│       Low      CATEGORY SPECIALIZATION      High  │
└────────────────────────────────────────────────┘

Dynamics: The company says many competitors exist across its individual product lines, but none offers the same end-to-end breadth spanning imaging, CAD/CAM, consumables, implants, and aligners. That breadth is a double-edged sword — it provides cross-selling opportunities but also means DENTSPLY SIRONA competes against specialists (for example, aligner-focused rivals) that may out-innovate in a single category.

---

5. Strategic Strengths & Risks

Strengths (Moat Sources)

• Unmatched category breadth: Few, if any, competitors span imaging equipment, CAD/CAM, implants, aligners, and consumables under one roof, supporting cross-selling and bundled distributor relationships.
• Entrenched distributor network: Deep, long-standing relationships with Henry Schein, Patterson, and other distributors create switching friction for both the company and its channel partners.
• Global manufacturing footprint: Facilities worldwide, including several sole-source plants for specific products, support scale economics once running efficiently.

Risks

1. Declining sales base: 2025 net sales fell about 3% (4.3% in constant currency) — the restructuring and ERP investments are happening against a shrinking, not growing, top line.
2. GAAP operating loss: A reported operating loss of $422 million for 2025 (versus 13.8% adjusted operating margin) reflects impairments and one-time charges that complicate reading the underlying business trend.
3. Distributor concentration: Henry Schein (13% of net sales) and Patterson (11% of receivables) are large enough that a disrupted relationship with either would materially affect results.
4. Execution risk on ERP and restructuring: A multi-year global ERP rollout carries cost-overrun and disruption risk, layered on top of the 2026 restructuring plan.
5. Legal/regulatory overhang: A German criminal tax investigation into 2016–2017 intercompany loans and residual litigation from a 2022 internal investigation remain unresolved.
6. Tariffs and China exposure: Trade tariffs and China's volume-based procurement programs pressure both costs and pricing in a business where roughly two-thirds of sales occur outside the U.S.

---

6. Financial Overview

---

7. Summary Conclusion

DENTSPLY SIRONA's moat rests on being the rare dental supplier with genuine end-to-end breadth — imaging, CAD/CAM, implants, aligners, and consumables — sold through entrenched distributor relationships that would be difficult for any single competitor to replicate quickly. That structural strength, however, is currently masked by a shrinking top line, a GAAP operating loss driven by restructuring and impairment charges, and unresolved legal matters tied to a multi-year German tax investigation. The biggest forward risk is whether the 2026 restructuring plan and ERP modernization actually translate the company's category breadth into renewed sales growth, rather than simply cutting costs around a business that keeps contracting.